| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.02B | +6.8% |
| Cost of Revenue | $263.7M | +10.2% |
| Gross Profit | $759.1M | +5.6% |
| R&D Expense | $73.0M | -25.0% |
| SG&A Expense | $432.1M | +5.9% |
| Operating Income | $228.0M | +32.6% |
| Pre-tax Income | $243.0M | +34.7% |
| Income Tax | $52.9M | +69.3% |
| Net Income | $190.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $295.6M | +18.1% |
| Accounts Receivable | $213.2M | +29.7% |
| Inventory | $299.0M | +26.2% |
| Current Assets | $983.3M | +13.7% |
| Total Assets | $2.08B | +6.1% |
| Current Liabilities | $159.2M | +13.6% |
| Total Liabilities | $229.8M | +6.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $178.5M | -35.4% |
| Capital Expenditures | $74.0M | +30.1% |
| Investing Cash Flow | -$110.4M | +70.6% |
| Financing Cash Flow | -$110.0M | -303.1% |
| Free Cash Flow | $104.4M | -52.4% |
| +27.5% |
| EPS (Basic) | $1.89 | +27.7% |
| EPS (Diluted) | $1.85 | +28.5% |
| Stockholders' Equity |
| $1.85B |
| +6.0% |